BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2830499)

  • 1. A new genetic approach for studying hormonal regulation of urokinase-type plasminogen activator gene expression in LLC-PK1 cells.
    Hofstetter P; Kikinis Z; Altus MS; Pearson D; Nagamine Y
    Mol Cell Biol; 1987 Dec; 7(12):4535-41. PubMed ID: 2830499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hsp70 mRNA accumulates in LLC-PK1 pig kidney cells treated with calcitonin but not with 8-bromo-cyclic AMP.
    Andrus L; Altus MS; Pearson D; Grattan M; Nagamine Y
    J Biol Chem; 1988 May; 263(13):6183-7. PubMed ID: 3360780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca2+ potentiates cAMP-dependent expression of urokinase-type plasminogen activator gene through a calmodulin- and protein kinase C-independent mechanism.
    Ziegler A; Hagmann J; Kiefer B; Nagamine Y
    J Biol Chem; 1990 Dec; 265(34):21194-201. PubMed ID: 1701176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells.
    Ziegler A; Knesel J; Fabbro D; Nagamine Y
    J Biol Chem; 1991 Nov; 266(31):21067-74. PubMed ID: 1718970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence of urokinase-type-plasminogen-activator induction on cyclic AMP-dependent protein kinase activation in LLC-PK1 cells.
    Jans DA; Resink TJ; Hemmings BA
    Biochem J; 1987 Apr; 243(2):413-8. PubMed ID: 2820380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of a plasminogen activator gene by cyclic AMP in a homologous cell-free system. Involvement of cyclic AMP-dependent protein kinase in transcriptional control.
    Nakagawa J; von der Ahe D; Pearson D; Hemmings BA; Shibahara S; Nagamine Y
    J Biol Chem; 1988 Feb; 263(5):2460-8. PubMed ID: 2828371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene.
    Marksitzer R; Stief A; Menoud PA; Nagamine Y
    J Biol Chem; 1995 Sep; 270(37):21833-8. PubMed ID: 7665606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression.
    Botteri FM; Ballmer-Hofer K; Rajput B; Nagamine Y
    J Biol Chem; 1990 Aug; 265(22):13327-34. PubMed ID: 1695907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of protein synthesis in LLC-PK1 cells increases calcitonin-induced plasminogen-activator gene transcription and mRNA stability.
    Altus MS; Pearson D; Horiuchi A; Nagamine Y
    Biochem J; 1987 Mar; 242(2):387-92. PubMed ID: 3593259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of uPA but not NF-IL3A by calcitonin is dependent on Erk1/2 phosphorylation in porcine renal cell line LLC-PK1.
    Nakamura M; Yang Q; Ozaki T; Nakamura Y; Yamasaki H; Mori I; Kakudo K
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1483-8. PubMed ID: 11820789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone coordinately inhibits plasminogen activator gene expression and enzyme activity in porcine kidney cells.
    Pearson D; Altus MS; Horiuchi A; Nagamine Y
    Biochem Biophys Res Commun; 1987 Feb; 143(1):329-36. PubMed ID: 3827925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and desensitization of plasminogen activator gene expression by tumor promoters.
    Degen JL; Estensen RD; Nagamine Y; Reich E
    J Biol Chem; 1985 Oct; 260(23):12426-33. PubMed ID: 3862668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced stability of urokinase-type plasminogen activator mRNA in metastatic breast cancer MDA-MB-231 cells and LLC-PK1 cells down-regulated for protein kinase C--correlation with cytoplasmic heterogeneous nuclear ribonucleoprotein C.
    Nanbu R; Montero L; D'Orazio D; Nagamine Y
    Eur J Biochem; 1997 Jul; 247(1):169-74. PubMed ID: 9249023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LLC-PK1 cell mutants in cAMP metabolism respond normally to phorbol esters.
    Jans DA; Hemmings BA
    FEBS Lett; 1986 Sep; 205(1):127-31. PubMed ID: 3017754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of cAMP-mediated gene induction: examination of renal epithelial cell mutants affected in the catalytic subunit of the cAMP-dependent protein kinase.
    Pearson D; Nigg EA; Nagamine Y; Jans DA; Hemmings BA
    Exp Cell Res; 1991 Jan; 192(1):315-8. PubMed ID: 1898592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a mutant LLC-PK1 cell line defective in hormonal responsiveness. A pleiotropic lesion in receptor function.
    Jans DA; Resink TJ; Wilson LE; Reich E; Hemmings BA
    Eur J Biochem; 1986 Oct; 160(2):407-12. PubMed ID: 3021458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redundant regulation of urokinase plasminogen activator transcription by the two major isozymes of cAMP-dependent protein kinase.
    Mira-y-Lopez R; Jaramillo S; Waxman S
    J Biol Chem; 1992 Nov; 267(32):23063-8. PubMed ID: 1331075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staurosporine stimulates expression of the urokinase-type (u-PA) plasminogen activator in LLC-PK1 cells.
    Dierks-Ventling C; Knesel J; Nagamine Y; Hemmings BA; Pehling G; Fischer F; Fabbro D
    Int J Cancer; 1989 Nov; 44(5):865-70. PubMed ID: 2583867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel LLC-PK1 renal epithelial cell mutant impaired in in vivo down-regulation of cAMP-mediated hormonal response.
    Jans DA; Resink TJ; Hemmings BA
    Arch Biochem Biophys; 1991 Mar; 285(2):377-81. PubMed ID: 1716864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathway of urokinase-type plasminogen activator induction in the T47D and LLC-PK1 cell lines.
    Jans DA; Dierks-Ventling C; Hemmings BA
    Exp Cell Res; 1987 Sep; 172(1):76-83. PubMed ID: 3653259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.